A European Distribution Footprint
implementing a competitive and responsive network
In the intricate landscape of the medtech, characterized by intricate regulatory frameworks, complex manufacturing processes, and global distribution networks, the concept of a global supply chain takes center stage. For a major pharmaceutical company, maintaining a reliable and resilient supply chain is not just a logistical imperative but a critical element in ensuring the availability of life-saving medications worldwide.
The global supply chain of Biorad extends across continents, encompassing the sourcing of raw materials, intricate manufacturing processes, stringent quality control measures, and the distribution of pharmaceutical products to diverse markets. The significance of a reliable supply chain in this context cannot be overstated.
Supply Chain rationalization. A strategic roadmap from strategy to implementation.
This project was quite the journey. We supported Biorad in designing and determining a strategic roadmap to transition from nine warehouses to two hub locations in Europe. First, the locations were identified, making optimal use of existing infrastructure, forming the ideal end state. Subsequently, various scenarios were modeled to calculate the path to the final situation.
Once the network structure was established, the focus shifted to organizing and executing transportation, services, and the tender process. In this process, we also supported the entire phase of contracting and transitioning to the new service providers. We analyzed various scenarios incorporating the proposals from logistics service providers.
In this project we used a set of supply chain network models to simulate the different scenario’s and simulate the performance and lead-times: Simulation module of our Spanning Tree platform, Multi-echelon inventory optimization and costs database.
Project partners:
